Paolo Cavazza, 10% Owner at SCICLONE PHARMACEUTICALS INC (SCLN), bought 200 shares at $2.00 ($400) on 2008-01-14, disclosed to the SEC on 2008-01-24.
Open-market purchase of $400 SCLN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| SNGX | SELL | 2017-12-01 | $1.2M | — | Filing → |
| SCLN | SELL | 2012-05-02 | $33.2M | — | Filing → |
| RGRX.OB | BUY | 2011-01-07 | $600K | — | Filing → |